Private EquityScreenerRefer

MARKET INSIGHTS

  • EventsNEWPrivate market milestones
  • NewsPrecize daily pulse
  • BlogsIn-depth articles and opinions

GUIDES

Explore Now
  • Unlisted SharesStep-by-step · KYC
  • BuyingStep-by-step · KYC
  • SellingExit in 24 - 48 hours
  • Pre-IPOReturns · risks · case studies
  • Tax GuideBudget 2026 changes
  1. Home
  2. Unlisted share news
  3. PHARMEASY SECURES $216 MILLION FUNDING LED BY MANIPAL GROUP, FACES VALU…

PHARMEASY SECURES $216 MILLION FUNDING LED BY MANIPAL GROUP, FACES VALUATION CUT

30 Apr 2024

Add as preferred source
Key Takeaways

  • Investor Trust Amid Challenges:

    • PharmEasy maintains investor trust, leveraging support for market fortification despite valuation adjustments and debt repayment challenges.

  • Market Fortification and Growth Goals:

    • The company aims to overcome hurdles, reinforce its market stance, and drive long-term growth objectives with substantial financial backing.

  • Investor Trust Amid Challenges:

    • PharmEasy maintains investor trust, leveraging support for market fortification despite valuation adjustments and debt repayment challenges.

  • Market Fortification and Growth Goals:

    • The company aims to overcome hurdles, reinforce its market stance, and drive long-term growth objectives with substantial financial backing.

pharmeasy unlisted shares

API Holdings (Pharmeasy)

-8.09%

Expert Analysis

PharmEasy Secures $216M Funding Led by Manipal Group Amid Valuation Decline.

Expert Analysis:

  • Funding Infusion Led by MEMG: PharmEasy secures Rs 1,804 crore ($216 million) funding led by Ranjan Pai’s MEMG, indicating investor confidence.

  • Significant Valuation Decline: The valuation experienced a sharp decline of approximately 90%, now standing at $710 million.

  • Funding Breakdown: Valuation drops sharply from $5.6 billion in 2021; MEMG’s family office leads with Rs 800 crore, backed by Prosus, Temasek, and 360 One Portfolios with Rs 221 crore, Rs 183 crore, and Rs 200 crore, respectively. Also, CDPQ Private Equity, WSSS Investments, Goldman Sachs, and Evolution Debt Capital invested Rs 400 crore collectively.

  • Debt Settlement Efforts: Efforts are underway to raise Rs 3,500 crore to settle debts incurred from defaulting on Goldman Sachs' loan terms.

  • Valuation Reduction History: Valuation was previously reduced by 50% by Janus Henderson and further by 21.4 percent to $4.4 billion as of February 2023 by Neuberger Berman.

Publisher:TNEC 24*7